Mirae Asset Healthcare Fund Direct Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 47.230 ↓ -0.32%
[as on 16 June, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Mirae Asset Healthcare Fund Direct Growth and its peers as on 16 June, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Mirae Asset Healthcare Fund Direct Growth 10.48% -0.32% -1.06% -0.81% 9.83% 11.2% 24.92% 15.53% 24.71%-
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -7.04% 0.14% 2.46% -0.4% 5.23% -6.27% 8.6% 14.02% 15.37% 14.89%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -4.4% 0.46% 3.16% 3.43% 6.82% -0.62% 11.11% 10.73% 12.59% 12.73%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 12.03% -0.55% 0.9% 1.87% 12.8% 11.21% 25.19% 16.73% 24.52% 14.54%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 2.67% 0.72% 1.75% 0.68% 12.08% 3.47% 18.27% 19.3% 18.87% 16.22%
SBI PSU Fund - DIRECT PLAN - GROWTH 2.88% -0.15% 0.43% -0.64% 2.03% 9.51% 29.34% 24.15% 19.73% 15.91%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--- 8.32% 77.37% 27.95% -10.87% 36.86% 41.36% -2.65%

Discrete returns (monthly)

MonthAug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026
Returns -1.25% -0.93% 1.89% -0.38% -0.71% -5.19% 7.4% -3.5% 6.96% 3.31%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.65% 5.44%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.92% 0.01% (Arbitrage: 0.00%) 0.00% 0.00% 0.07%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.20%
Divi's Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.93%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.94%
JB Chemicals & Pharmaceuticals Ltd.JBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology6.88%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services6.15%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology5.06%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology4.32%
Dr. Reddy's Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.31%
Fortis Healthcare Ltd.FORTIS (INE061F01013)Healthcare Services3.73%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology3.56%
Aster DM Healthcare Ltd.ASTERDM (INE914M01019)Healthcare Services3.44%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.37%
IPCA Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.32%
Krishna Institute of Medical Sciences Ltd.KIMS (INE967H01025)Healthcare Services3.26%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.25%
Sai Life Sciences Ltd.SAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.03%
Onesource Specialty Pharma Ltd.ONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology2.91%
Eris Lifesciences Ltd.ERIS (INE406M01024)Pharmaceuticals & Biotechnology2.67%
Dr. Lal Path labs Ltd.LALPATHLAB (INE600L01024)Healthcare Services1.95%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.88%
Mankind Pharma Ltd.MANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.67%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.27%
Anthem Biosciences Ltd.ANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.25%
Narayana Hrudayalaya Ltd.NH (INE410P01011)Healthcare Services1.17%
Max Healthcare Institute Ltd.MAXHEALTH (INE027H01010)Healthcare Services1.11%
Rubicon Research Ltd.RUBICON (INE506V01022)Pharmaceuticals & Biotechnology0.85%
Sagility Ltd.SAGILITY (INE0W2G01015)IT - Services0.54%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology0.49%
Sudeep Pharma Ltd.INE0QPI01025Pharmaceuticals & Biotechnology0.44%
Deepak Nitrite Ltd.DEEPAKNTR (INE288B01029)Chemicals & Petrochemicals0.43%
Neogen Chemicals Ltd.NEOGEN (INE136S01016)Chemicals & Petrochemicals0.42%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology0.09%

Debt

NameRatingWeight %
Mirae Asset Liquid Fund-Direct Plan-Growth0.01%
Portfolio data is as on date 31 March, 2026

NAV history

Mirae Asset Healthcare Fund Direct Growth - 30 days NAV (Net asset value) history

DateNAV% change
16 June, 202647.230 -0.32%
15 June, 202647.382 -0.76%
12 June, 202647.747 0.44%
11 June, 202647.536 0.28%
10 June, 202647.403 -0.7%
9 June, 202647.737 0.78%
8 June, 202647.369 0.04%
5 June, 202647.350 0.71%
4 June, 202647.016 0.45%
3 June, 202646.806 0.52%
2 June, 202646.563 -0.42%
1 June, 202646.761 -0.9%
29 May, 202647.185 -1.34%
27 May, 202647.827 0.11%
26 May, 202647.774 -0.26%
25 May, 202647.900 0.35%
22 May, 202647.734 -1.55%
21 May, 202648.484 0.26%
20 May, 202648.356 0.46%
19 May, 202648.135 0.8%
18 May, 202647.752 0.29%
15 May, 202647.615 -0.14%
14 May, 202647.681 2.19%
13 May, 202646.657 0.12%
12 May, 202646.602 -1.64%
11 May, 202647.381 0.48%
8 May, 202647.154 0.53%
7 May, 202646.905 0.36%
6 May, 202646.738 1.45%
5 May, 202646.070

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
    The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 47.230 as on 16 June, 2026.
  • What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
    The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 10.48% as on 16 June, 2026.
  • What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
    The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 11.2% as on 16 June, 2026.
  • What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 24.92% as on 16 June, 2026.
  • What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 15.53% as on 16 June, 2026.